In 8 patients with coronary artery disease and symmetrical left ventricular contraction, an echocardiographic study of left ventricular function was performed before and 3 minutes after the administration of 0-6 mg nitroglycerin sublingually. The left ventricular end-diastolic diameter decreasedfrom 5i2 ± 0-2 to 4 9 ±02 cm (P<0 05) and the end-systolic diameter from 4-2±0-2 to 3 7±0 2 cm (P<0 001). The estimated stroke volume did not change significantly, while the cardiac output increased, 5'8±0-6 to 7.7±0 6 1 min-' (P <0-001) and the heart rate increasedfrom 72±5 to 90±6 (P<0-001). The mean arterial blood pressure decreased from 105 ± 4 to 88 ±3 mmHg (P<0 001). The ejection fraction increased from 53 ±3 per cent to 65±6 per cent (P<0.001) and the mean velocity of circumferentialfibre shortening (Vcp)from 0J81 ±005 to 1415 ±0-10 circumferences per second (P<0-001). The estimated midsystolic midwall stress decreased from 155±14gCm-2 to 102±12gCm-2 after nitroglycerin (P<0-001).
estimating left ventricular minor axis, particularly in serial studies, using a patient as his own control (Pombo, Troy, and Russell, 1971; Fortuin et al., 1971; Gibson, 1973; Redwood, Henry, and Epstein, 1974) . Though two recent investigations have shown a decrease in the echographic left ventricular dimension after nitroglycerin administration (DeMaria et al., 1974; Burggraf and Parker, 1974) , no reports have been published about its effects on estimated wall stress in man. In the present study, changes in left ventricular afterload after nitroglycerin were estimated, using calculations based on a thick-wall spherical model of the chamber. This method probably allows a closer assessment of changes in myocardial oxygen demand than pressure and volume measurements alone. Changes in afterload can then be correlated with concurrent changes in heart rate and in the mean velocity of internal dimension shortening, used as an index of contractility, thus providing an estimate of all three major determinants of myocardial oxygen consumption. The systolic blood pressure decreased from 142±7 (SEM) mmHg in the control period to 116±-17 numHg (P < 0.001) and the diastolic pressure from 84±3 to 74±2 mmHg (P < 0001). The calculated mean blood pressure also decreased significantly, from 105±4 to 88±3 mmHg (P < 0-001). The end-diastolic and end-systolic dimensions of the left ventricle both decreased significantly, from 5-2 ±0-2 cm to 4 9 ±0-2 cm (P < 0.05), and from 4-2 ±0-2 cm to 3-7 ±0-2 cm (P < 0.001), respectively. Corresponding changes were seen in the calculated left ventricular enddiastolic and end-systolic volumes, from 155 ±15 ml to 139 ±13 ml (P < 0 05) and from 75 ±10 to 53±11 (P <0.001), respectively. The end-diastolic posterior wall thickness did not change significantly after nitroglycerin. The cardiac output, as estimated from the left ventricular volumes and the heart rate, was increased from 5-8±0 6 l min-' to 7-7±0-6 1 min -1 (P < 0-001). However, with one exception, this was the result of an increase in heart rate from 72 ±5 to 90 ±6 beats per minute (P < 0-001), while the stroke volume did not change significantly from the resting value of 80 ml (Fig. 2) . The total peripheral resistance, however, decreased from 18±4 to 11±1 units (P< 0-001) .
The ejection fraction increased after nitroglycerin administration from 53 ±3 per cent to 65 ±6 per cent (P < 0.001) and the VCF increased from 0-81 ± 0 05 to 115±0.10 circs-' (P<0-001). The calculated midsystolic midwall stress decreased from 155 ±14 to 102 ±11 gcm -2 (P < 0-001). No significant changes were seen in the rate corrected systolic time intervals: LVETI was 400±9 before and 390 ±6 at 3 minutes after nitroglycerin; PEPI group.bmj.com on October 22, 2017 -Published by http://heart.bmj.com/ Downloaded from Effect of suiblingual nitroglycerin on cardiac performance 1275 was 141 ±3 and 143 ±3 and QA2I was 542 ±8 and 531 ±6 before and after nitroglycerin.
Discussion
Recently, interest has been growing in the use of agents which decrease left ventricular afterload for the treatment of patients with myocardial infarction (Franciosa et al., 1974; Hirshfeld et al., 1974) or contraction abnormalities in chronic ischaemic heart disease (Helfant et al., 1974; Dove, Shah, and Schlciner, 1974) . In the present study, echocardiographic techniques were used for the estimation of afterload as expressed by the left ventricular wall stress, before and after the administration of nitroglycerin. These changes in afterload can be related to the attendant variations in Vc, (Fig. 3) . Since the long axis of the left ventricle cannot be measured echocardiographically, a thick-wall spherical model is assumed, and the formula used allows estimations of wall stress to be made at any given level through the wall thickness. This model can, however, only be applied to symmetrically contracting ventricles. Ratshin, Rackley, and Russell (1974) measured sphygmomanometrically, can be used. The peak systolic pressure is assumed to occur at mid-ejection and the left ventricular dimension can be estimated at this moment as described above.
Although the peak left ventricular wall stress usually occurs early in systole, the wall stress at mid-ejection is probably comparable in any individual patient before and after acute interventions. If the wall stress falls nearly linearly from an early systolic peak (Mirsky, 1968) , the midsystolic measurement can be used as an approximate measure of the mean systolic stress and therefore correlated with the mean velocity of circumferential fibre shortening.
In spite of the usually reported good correlations between echocardiographic and angiocardiographic left ventricular dimensions, there is considerable scatter at all levels Gibson, 1973) . The wide confidence margins are reflected in the absolute values for wall stress. However, recent studies (Redwood et al., 1974) have supported the use of echocardiographic left ventricular dimensions in the study of the effects of haemodynamic interventions. In the present context, directional changes in wall stress are emphasized. Fig. 3 shows that in all the patients, a decrease in left ventricular afterload was accompanied by an increase in Vcp, thus illustrating a modified forcevelocity relation. With decreased afterload and total peripheral resistance, the increased VCF cannot be attributed to increased left ventricular contractility, even though the left ventricular end-diastolic volume was decreased. Isolated muscle studies (Zelis et al., 1970a, b) have failed to show any alteration in contractility after moderate doses of nitroglycerin. However, in man, nitroglycerin may elicit reflex sympathetic activity as a result of its vasodilator action (Zelis et al., 1970a, b) . In a recent study, DeMaria et al. (1974) , reported a small decrease in VcF after nitroglycerin. In that study, however, left ventricular ejection time was measured from the beginning of the QRS complex to the time of maximal anterior position of the posterior left ventricular wall, assuming a pre-ejection period of 50 ms. This method is probably less reliable than that using the indirect carotid tracing; the implied prolongation of left ventricular ejection time after nitroglycerin is also at variance with results of this and previous studies (Sawayama et al., 1973) . Redwood et al. (1974) found an increase in VCF from 1*3 to 1-7 circ s -in their normal subjects, a change similar to that observed in our patients. The increase in cardiac output found in the present study exceeds the insignificant increases observed by DeMaria et al. (1974) , and Burggraf and Parker (1974) . The changes in cardiac output are probably largely determined by the relative predominance of venous or arteriolar dilatation (Mason and Braunwald, 1965) . A dominant arteriolar depressant effect is likely in our group of patients.
Opinion is still divided as to whether nitroglycerin relieves angina pectoris mainly by its effect on left ventricular pump function or by coronary vasodilatation (Cohn and Gorlin, 1974) . In 1867, Brunton reported after Gamgee that amyl nitrite 'greatly lessens the arterial tension both in animals and man ... which led me to try it in angina pectoris'. The present study confirms earlier reports (Brachfeld, Bozer, and Gorlin, 1959; DeMaria et al., 1974; Burggraf and Parker, 1974) 
